13.94
price up icon4.65%   0.62
after-market Handel nachbörslich: 13.94
loading
Schlusskurs vom Vortag:
$13.32
Offen:
$13.44
24-Stunden-Volumen:
1.21M
Relative Volume:
1.72
Marktkapitalisierung:
$814.69M
Einnahmen:
$1.12B
Nettoeinkommen (Verlust:
$55.30M
KGV:
14.67
EPS:
0.95
Netto-Cashflow:
$-30.30M
1W Leistung:
+41.24%
1M Leistung:
+33.14%
6M Leistung:
-13.68%
1J Leistung:
-5.94%
1-Tages-Spanne:
Value
$13.21
$14.22
1-Wochen-Bereich:
Value
$9.955
$14.22
52-Wochen-Spanne:
Value
$9.20
$21.48

Embecta Corp Stock (EMBC) Company Profile

Name
Firmenname
Embecta Corp
Name
Telefon
(862) 401-0000
Name
Adresse
1209 ORANGE STREET, WILMINGTON
Name
Mitarbeiter
2,100
Name
Twitter
Name
Nächster Verdiensttermin
2025-08-08
Name
Neueste SEC-Einreichungen
Name
EMBC's Discussions on Twitter

Vergleichen Sie EMBC mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Medical Instruments & Supplies icon
EMBC
Embecta Corp
13.94 779.02M 1.12B 55.30M -30.30M 0.95
Medical Instruments & Supplies icon
ISRG
Intuitive Surgical Inc
482.35 171.42B 9.15B 2.63B 1.99B 7.17
Medical Instruments & Supplies icon
BDX
Becton Dickinson Co
195.96 55.88B 21.39B 1.61B 2.55B 5.56
Medical Instruments & Supplies icon
ALC
Alcon Inc
86.48 42.55B 9.93B 1.12B 1.43B 2.26
Medical Instruments & Supplies icon
RMD
Resmed Inc
288.28 41.48B 5.15B 1.40B 1.65B 9.51
Medical Instruments & Supplies icon
WST
West Pharmaceutical Services Inc
246.22 17.25B 2.90B 467.20M 306.90M 6.37

Embecta Corp Stock (EMBC) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-04-10 Eingeleitet Mizuho Neutral
2024-12-02 Hochstufung Morgan Stanley Underweight → Equal-Weight
2024-11-27 Hochstufung BTIG Research Neutral → Buy
2023-10-20 Eingeleitet Wolfe Research Peer Perform
2023-01-06 Herabstufung Morgan Stanley Equal-Weight → Underweight
2022-09-08 Eingeleitet BTIG Research Neutral
2022-08-01 Eingeleitet Morgan Stanley Equal-Weight
2022-06-21 Eingeleitet BofA Securities Underperform
Alle ansehen

Embecta Corp Aktie (EMBC) Neueste Nachrichten

pulisher
Aug 12, 2025

Embecta Corp. Reports Record Revenue and Debt Reduction - TipRanks

Aug 12, 2025
pulisher
Aug 12, 2025

Wall Street Analysts Predict a 25.69% Upside in Embecta Corp. (EMBC): Here's What You Should Know - Yahoo Finance

Aug 12, 2025
pulisher
Aug 12, 2025

Embecta Corp. (NASDAQ:EMBC) Q3 2025 Earnings Call Transcript - Insider Monkey

Aug 12, 2025
pulisher
Aug 11, 2025

Embecta To Go Ex-Dividend On August 29th, 2025 With 0.15 USD Dividend Per Share - 富途牛牛

Aug 11, 2025
pulisher
Aug 11, 2025

Intraday Charts Show Spike in Embecta Corp. ActivitySecure Return Focused Investment Plan Released - beatles.ru

Aug 11, 2025
pulisher
Aug 11, 2025

Market Cool On Embecta Corp.'s (NASDAQ:EMBC) Earnings - 富途牛牛

Aug 11, 2025
pulisher
Aug 11, 2025

Embecta Corp. shares rise 1.06% intraday due to positive outlook in the insulin delivery device market. - AInvest

Aug 11, 2025
pulisher
Aug 11, 2025

Mizuho raises Embecta stock price target to $14 on strong Q3 results - Investing.com Nigeria

Aug 11, 2025
pulisher
Aug 11, 2025

Mizuho raises Embecta stock price target to $14 on strong Q3 results By Investing.com - Investing.com South Africa

Aug 11, 2025
pulisher
Aug 10, 2025

Bloomberg Finance Expert Creates Essential Title for News Passage - AInvest

Aug 10, 2025
pulisher
Aug 10, 2025

What makes Embecta Corp. stock price move sharplySmart Exit Timing Suggestions - mustnews.co.kr

Aug 10, 2025
pulisher
Aug 09, 2025

Embecta Corp's Q3 2025 Outperformance: A Strategic Re-rating Opportunity Amid Margin Stability and Debt Reduction - AInvest

Aug 09, 2025
pulisher
Aug 09, 2025

Embecta's 2025 Revenue Outlook: Navigating Regional Challenges and Valuation Opportunities - AInvest

Aug 09, 2025
pulisher
Aug 09, 2025

This Embecta Insider Increased Their Holding By 20% Last Year - simplywall.st

Aug 09, 2025
pulisher
Aug 09, 2025

Embecta 2025 Q3 Earnings Strong Performance as Net Income Surges 209.5% - AInvest

Aug 09, 2025
pulisher
Aug 09, 2025

Embecta outlines revenue range of $1.078B-$1.085B for 2025 amid U.S. strength and China headwinds - MSN

Aug 09, 2025
pulisher
Aug 09, 2025

Embecta Corporation Reports Strong Q3 2025 Results - TipRanks

Aug 09, 2025
pulisher
Aug 08, 2025

What are the risks of holding Embecta Corp.Weekly Alpha Generating Watchlist - thegnnews.com

Aug 08, 2025
pulisher
Aug 08, 2025

Healthcare Stocks Move in Friday's Pre-Market Session: OptimizeRx, Embecta, and More - AInvest

Aug 08, 2025
pulisher
Aug 08, 2025

Embecta Beat Estimates And Raised Its Outlook For The Year - Finimize

Aug 08, 2025
pulisher
Aug 08, 2025

Embecta (EMBC.O) Surges 16.55% — But No News. What’s Driving This Move? - AInvest

Aug 08, 2025
pulisher
Aug 08, 2025

Embecta Shares Rise on 2Q Profit, Revenue Beat - 富途牛牛

Aug 08, 2025
pulisher
Aug 08, 2025

Embecta stock gets a boost on Q3 beats, raised guidance - Drug Delivery Business

Aug 08, 2025
pulisher
Aug 08, 2025

Embecta Q3 2025 Earnings Call Transcript - MarketBeat

Aug 08, 2025
pulisher
Aug 08, 2025

Embecta Corp.'s Q3 2025 Earnings Call: Navigating Key Contradictions in Tariffs, Demand, and Financial Strategy - AInvest

Aug 08, 2025
pulisher
Aug 08, 2025

Embecta projects 2025 revenue range of $1.078B-$1.085B, citing US strength and Chinese challenges. - AInvest

Aug 08, 2025
pulisher
Aug 08, 2025

Embecta Corp. SEC 10-Q Report - TradingView

Aug 08, 2025
pulisher
Aug 08, 2025

Transcript : Embecta Corp., Q3 2025 Earnings Call, Aug 08, 2025 - MarketScreener

Aug 08, 2025
pulisher
Aug 08, 2025

Earnings call transcript: Embecta Q3 2025 beats expectations, stock surges By Investing.com - Investing.com South Africa

Aug 08, 2025
pulisher
Aug 08, 2025

Earnings call transcript: Embecta Q3 2025 beats expectations, stock surges - Investing.com

Aug 08, 2025
pulisher
Aug 08, 2025

Embecta Q3 FY 2025 slides: Revenue jumps 8.4%, guidance raised as stock surges - Investing.com Nigeria

Aug 08, 2025
pulisher
Aug 08, 2025

Embecta Corp. Shares Soar 17.76% on Strong Q3 Earnings - AInvest

Aug 08, 2025
pulisher
Aug 08, 2025

Embecta Boosts FY25 Adj. EPS Outlook; Stock Soars 18%Update - Nasdaq

Aug 08, 2025
pulisher
Aug 08, 2025

Embecta Corp. Q3 Profit Increases, Beats Estimates - Nasdaq

Aug 08, 2025
pulisher
Aug 08, 2025

Embecta Shares Rise Over 2% After Third-Quarter Results Beat Estimates - MSN

Aug 08, 2025
pulisher
Aug 08, 2025

Embecta Corp. Reports Third Quarter Fiscal 2025 Financial Results - TradingView

Aug 08, 2025
pulisher
Aug 08, 2025

Embecta Corp. Declares Quarterly Cash Dividend, Payable on September 15, 2025 - MarketScreener

Aug 08, 2025
pulisher
Aug 08, 2025

Embecta earnings beat by $0.35, revenue topped estimates - Investing.com

Aug 08, 2025
pulisher
Aug 08, 2025

Medical supplies company Embecta beats Q3 estimates, raises FY forecast - MarketScreener

Aug 08, 2025
pulisher
Aug 08, 2025

Embecta shares rise over 2% as third quarter results surpass expectations - Investing.com Nigeria

Aug 08, 2025
pulisher
Aug 08, 2025

Embecta raises FY23 outlook, Q3 revenue up 10% YoY. - AInvest

Aug 08, 2025
pulisher
Aug 08, 2025

Press Release: Embecta Announces Quarterly Cash Dividend - 富途牛牛

Aug 08, 2025
pulisher
Aug 08, 2025

Embecta's Quarterly Dividend Announcement: A Strategic Indicator of Financial Health and Investor Confidence - AInvest

Aug 08, 2025
pulisher
Aug 08, 2025

Embecta declares quarterly dividend of $0.15 per share By Investing.com - Investing.com Canada

Aug 08, 2025
pulisher
Aug 08, 2025

Embecta declares quarterly dividend of $0.15 per share - Investing.com India

Aug 08, 2025
pulisher
Aug 08, 2025

embecta Announces Quarterly Cash Dividend - The Manila Times

Aug 08, 2025
pulisher
Aug 07, 2025

An Overview of Embecta's Earnings - 富途牛牛

Aug 07, 2025
pulisher
Aug 06, 2025

The Ultra-Fine™ Pen Needle is now part of embecta - retailpharmacymagazine.com.au

Aug 06, 2025
pulisher
Aug 05, 2025

Diabetes Care Market to See Booming Growth 2025-2032 | Medtronic, Abbott, Pumps It, Inc., Embecta Corp - openPR.com

Aug 05, 2025
pulisher
Aug 04, 2025

Can Embecta Corp. Escape Recent Bear ChannelRisk Controlled Short Term Trade Plans Published - metal.it

Aug 04, 2025
pulisher
Aug 03, 2025

What institutional investors are buying Embecta Corp. stockInvest confidently with real-time updates - Jammu Links News

Aug 03, 2025

Finanzdaten der Embecta Corp-Aktie (EMBC)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$145.74
price up icon 3.74%
medical_instruments_supplies BAX
$24.11
price up icon 0.54%
$74.38
price up icon 3.18%
medical_instruments_supplies COO
$74.27
price up icon 2.17%
$68.98
price up icon 1.52%
medical_instruments_supplies WST
$246.22
price up icon 2.63%
Kapitalisierung:     |  Volumen (24h):